[PLACE]
22q11.2 deletion syndrome
Featured in 1 tracked story · first seen
Situations
Experimental therapies for neurodevelopmental genetic syndes
2 clusters · 3 sources · last updated
Latest: Fralin Biomedical Research Institute finds therapy bypasses 22q11.2 deletion effects
In July 2026, researchers reported that an AAV‑based gene‑replacement therapy restored the missing fragile X protein in mouse models, alleviating seizures, sensory hyperactivity, repetitive behavior, and EEG abnormalitie